Loading news...
IR strengthens its life sciences platform by acquiring Scinomix, adding automation workflow technologies for labs and pharma markets.
DAVIDSON, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Scinomix, Inc., expanding the company's life sciences portfolio.
Ingersoll Rand (NYSE: IR - Get Free Report) and Gorman-Rupp (NYSE: GRC - Get Free Report) are both industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent recommendations
DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial officer, and Scott Watson, senior vice president and general manager, Life Science Technologies, will present at the 2026 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 7:30 a.m. Pacific Time.
Corient Private Wealth LLC trimmed its position in Ingersoll Rand Inc. (NYSE: IR) by 5.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 229,095 shares of the industrial products company's stock after selling 13,786 shares during the period. Corient
DAVIDSON, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Jerome Guillen to its Board of Directors, effective January 1, 2026.
IR sees order growth and acquisitions lift 2025 outlook, while cash flow supports buybacks despite rising costs.
PHOENIX--(BUSINESS WIRE)---- $IR #globalmeet--GlobalMeet wins 2025 Global Tech Awards for Best Events Technology.
IR struggles with rising costs, mounting debt and currency headwinds, pressuring profitability and investor sentiment.
DAVIDSON, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, today announced the acquisition of Transvac Systems Ltd. (“Transvac”), a United Kingdom-based global supplier of ejector solutions and sustainable process technologies used to move, mix, and compress fluids and gases. Transvac will join the Industrial Technologies and Services (IT&S) segment.
IR posts solid Q3 results with revenues up 5.1% and earnings matching estimates, but trims full-year EPS outlook.
Ingersoll Rand Inc. ( IR ) Q3 2025 Earnings Call October 31, 2025 8:00 AM EDT Company Participants Matthew Fort - VP of Investor Relations, Global Financial Planning & Analysis Vicente Reynal - Chairman, CEO & President Vikram Kini - Senior VP & CFO Conference Call Participants Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division Julian Mitchell - Barclays Bank PLC, Research Division Jeffrey Sprague - Vertical Research Partners, LLC Andrew Kaplowitz - Citigroup Inc., Research Division Nigel Coe - Wolfe Research, LLC Joseph Ritchie - Goldman Sachs Group, Inc., Research Division Christopher Snyder - Morgan Stanley, Research Division Stephen Volkmann - Jefferies LLC, Research Division Joseph O'Dea - Wells Fargo Securities, LLC, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Nicole DeBlase - Deutsche Bank AG, Research Division David Raso - Evercore ISI Institutional Equities, Research Division Presentation Operator Hello, and thank you for standing by.
The headline numbers for Ingersoll (IR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ingersoll Rand (IR) came out with quarterly earnings of $0.86 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.84 per share a year ago.
DAVIDSON, N.C.--(BUSINESS WIRE)--Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, reported strong financial results for the third quarter 2025. “We delivered positive organic orders growth in the third quarter across both segments,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “Our performance demonstrates the resilience of our business, which combined with our strong balance sheet, ena.
Evaluate the expected performance of Ingersoll (IR) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
IR readies Q3 results with solid life sciences and acquisition gains, though margin pressures are likely to weigh.
DAVIDSON, N.C., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on December 4, 2025, to stockholders of record on November 13, 2025.
Ingersoll (IR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingersoll Rand continues to deliver strong revenue and cash flow growth, driven by acquisitions and higher pricing, despite declining profitability. IR's Industrial Technologies and Services segment faces organic volume declines, while Precision and Science Technologies posts robust revenue and profit gains. Management remains optimistic, raising guidance for 2025 with expected EBITDA of $2.10–$2.16 billion and ongoing acquisition activity fueling further growth.